.jpeg)
2026-03-30 07:09:03
Sunvozertinib, a next-gen EGFR-TKI, offers breakthrough efficacy for EGFR-mutated NSCLC patients. Designed to overcome resistance and tackle brain metastases, it provides a promising new option. Explore dosing guidelines, AE management, monitoring strategies, and long-term treatment insights.
2026-03-30 07:00:34
Lorlatinib, developed by Pfizer, is a groundbreaking third-generation ATP-competitive macrocyclic tyrosine kinase inhibitor targeting ALK and ROS1 mutations. With superior blood-brain barrier penetration and activity against resistant mutations, clinical data demonstrates unprecedented PFS超过3 years in frontline treatment, intracranial response rate of 83.3%, and transformative outcomes for advanced NSCLC patients. Explore its mechanism, global clinical evidence, administration guidelines, and AE management strategies.
2026-03-25 01:39:36
IRX4 as a transcription factor shows downregulated expression in colorectal cancer. Research reveals it can inhibit cancer cell proliferation and enhance chemotherapy sensitivity. This article analyzes IRX4 mechanisms and clinical application potential.
2026-03-25 01:28:42
Ponesimod (brand name PONVORY) is a selective S1P receptor modulator for treating adult relapsing multiple sclerosis. This article analyzes its mechanism, comparison with traditional medications, and safety features to assist patients and physicians in developing personalized treatment plans.
2026-03-24 04:46:55
Lemborexant (Dayvigo) is a dual orexin receptor antagonist for adult insomnia disorder treatment. This article details drowsiness, dizziness, sleep paralysis and other adverse reactions with monitoring points to help patients use medication safely.
2026-03-24 04:27:54
Pegcetacoplan is a complement C3 inhibitor for paroxysmal nocturnal hemoglobinuria (PNH) treatment. This article details injection reactions, infection risks and monitoring points to help patients use medication safely.
2026-03-24 04:11:29
Cabotegravir Sodium (Vocabria) is an HIV integrase inhibitor for HIV-1 infection treatment and PrEP. This article details headache, liver injury, allergic reactions and monitoring points to help patients use medication safely.
2026-03-24 03:56:40
Vericiguat (Verquvo) is an sGC stimulator for chronic heart failure treatment. This article details hypotension, anemia, gastrointestinal reactions and monitoring points to help patients use medication safely.
2026-03-20 03:27:09
Clonal hematopoiesis of indeterminate potential refers to somatic mutations in hematopoietic stem cells, associated with tumor development, with standardized research holding important value for precision medicine.
2026-03-20 03:20:58
Pegcetacoplan is a PEGylated complement C3 inhibitor used for treating adult paroxysmal nocturnal hemoglobinuria, providing comprehensive control of complement-mediated hemolytic reactions.
2026-03-20 03:13:56
Cabotegravir sodium is an integrase strand transfer inhibitor used for HIV-1 treatment and pre-exposure prevention, supporting long-acting injection regimens suitable for patients with adherence challenges.
2026-03-19 04:04:05
Eltrombopag is a novel oral TPO receptor agonist that stimulates bone marrow megakaryocytes to promote platelet production, providing non-immunosuppressive treatment options for patients with immune thrombocytopenia and aplastic anemia.
